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Abstract
Background: RAE-1 is a ligand of the activating receptor NKG2D expressed by NK cells, NKT, cdT and some CD8
+T
lymphocytes. RAE-1 is overexpressed in tumor cell lines and its expression is induced after viral infection and genotoxic
stress. We have recently demonstrated that RAE-1 is expressed in the adult subventricular zone (SVZ) from C57BL/6 mice.
RAE-1 is also expressed in vitro by neural stem/progenitor cells (NSPCs) and plays a non-immune role in cell proliferation.
The C57BL/6 mouse genome contains two rae-1 genes, rae-1d and rae-1e encoding two different proteins. The goals of this
study are first to characterize the in vivo and in vitro expression of each gene and secondly to elucidate the mechanisms
underlying their respective expression, which are far from known.
Principal Findings: We observed that Rae-1d and Rae-1e transcripts are differentially expressed according to tissues,
pathological conditions and cell lines. Embryonic tissue and the adult SVZ mainly expressed Rae-1d transcripts. The NSPCs
derived from the SVZ also mainly expressed RAE-1d. The interest of this result is especially related to the observation that
RAE-1d is a weak NKG2D ligand compared to RAE-1e. On the contrary, cell lines expressed either similar levels of RAE-1d and
RAE-1e proteins or only RAE-1e. Since the protein expression correlated with the level of transcripts for each rae-1 gene, we
postulated that transcriptional regulation is one of the main processes explaining the difference between RAE-1d and RAE-
1e expression. We indeed identified two different promoter regions for each gene: one mainly involved in the control of rae-
1d gene expression and the other in the control of rae-1e expression.
Conclusions/Significance: RAE-1d and RAE-1e differ with respect to their function and the control of their expression.
Immune function would be mainly exerted by RAE-1e and non-immune function by RAE-1d.
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Introduction
RAE-1 is a ligand of the activating receptor NKG2D expressed by
NK cells, NKT, cdTa n ds o m eC D 8
+T lymphocytes [1]. RAE-1
protein is a MHC (major histocompatibility complex) class I-related
molecule composed of 2 domains, a1a n da2 forming a groove
similartothe MHCclass Imoleculesbut whichistoo small to present
a peptide [2]. Five RAE-1 proteins have been described which are
encoded by 5 different rae-1 genes: a, b,c, d and e.T h eg e n o m eo ft h e
BALB/C mouse strain has four rae-1 genes: a, b, c and d, the 129/sv,
3g e n e s :a, b and c and the C57BL/6, only 2 genes: d and e.
Rae-1 transcripts have been first isolated from mouse
embryonic carcinoma F9 cell line among retinoic acid inducible
clones [3]. RAE-1 is overexpressed in tumor cell lines [1,4,5] and
its expression is induced after viral infection [6,7] and genotoxic
stress [8]. RAE-1 is constitutively expressed during embryogenesis,
mainly in the brain [9] whereas, in adult BALB/c mice, Rae-1
transcripts are not detected except in the adult spleen and liver
where very low amounts are found [1]. Higher levels of Rae-1
transcripts are detected in the liver of C57BL/6 mice and
interestingly this expression is circadianly regulated [10]. We have
recently demonstrated that, in C57BL/6 mice, RAE-1 expression
persists in one of the main area of adult neurogenesis, the
subventricular zone (SVZ) [11]. Moreover, neural stem/progen-
itor cells (NSPCs) derived from postnatal mouse SVZ express
RAE-1 and the expression of RAE-1 is lost after neural
differentiation. So far, RAE-1 is known for its immune functions.
We have demonstrated that RAE-1 also exerts a non-immune
function in cell proliferation of NSPCs [11].
The molecular mechanisms controlling the expression of each
rae-1 gene are far from known.
Nausch N. et al. showed that embryonic cell lines from C57BL/
6 mice lacking JUNB, a subunit of the AP-1 complex, expressed
higher level of RAE-1e than control cells lines whereas the
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e13466expression of RAE-1d was not enhanced [12]. This study suggests
for the first time that the molecular mechanisms controlling the
expression of rae-1d and rae-1e are different. The goals of our study
were thus to characterize the in vivo and in vitro expression of each
gene and to elucidate the mechanisms underlying their respective
expression.
We observed that Rae-1d and Rae-1e transcripts are differen-
tially expressed according to tissues, pathological conditions and
cell lines. SVZ and neurosphere cells expressed mainly RAE-1d.
Interestingly, RAE-1d is a poor NKG2D ligand compared to
RAE-1e. Because RAE-1d and RAE-1e protein expression level in
vitro correlated with the level of their respective transcripts, we
postulate that transcriptional regulation is one of the main
mechanisms explaining the difference between Rae-1d and Rae-
1e transcripts expression. We indeed identified two different
promoter regions for each gene, one upstream of exon 1, mainly
involved in the control of rae-1e gene expression and a second one,
upstream of a previously unknown exon, named exon 3b, mainly
involved in the control of rae-1d gene expression.
Results
RAE-1d and RAE-1e differ with respect to their expression
profile and NKG2D affinity
In silico study of rae-1d and rae-1e genes revealed that they are
located on chromosome 10 band A3 in the C57BL/6 genome,
adjacent but separated by 89.5 kb (Fig. 1A). This region also
contains genes encoding other NKG2D ligands like MULT1, H60c
(10A1) andH60b (10A3)[13].Rae-1dand Rae-1e GenBankcDNA
sequences contain 6 full exons (NM_020030 and NM_198193
respectively). However, analysis of the available genomic sequences,
based on the comparison with the Rae-1a cDNA sequence
(NM_009016) described by Nomura and coll. [9], allowed us to
identify 3 additional exons in both rae-1d and rae-1e genes. The
figure 1B represents the rae-1 genes. The coding sequence starts in
the middle of exon 5 and ends in the middle of exon 8. Exon 5
encodes the leader sequence, exons 6 and 7 encode the extracellular
a1a n da2 domains respectively and exon 8 the GPI anchor. The
main differences between the two genes lie within the sequences of
exon 6 and upstream of exon 1 but also in the length of intron 1.
These differences allowed us to design PCR primers to distinguish
the expression of Rae-1d and Rae-1e transcripts.
We analyzed the respective expression level of Rae-1d and Rae-
1e transcripts in vivo. We confirmed the presence of Rae-1
transcripts in embryonic tissues and detected Rae-1 transcripts in
adult tissues (Fig. 2A). Rae-1 was highly expressed in the liver and
undetectable in numerous parts of the brain except in the SVZ,
the main area of neurogenesis, where Rae-1 was weakly but
significantly detected. Both Rae-1d and Rae-1e transcripts were
expressed in liver and embryonic tissues (Fig. 2B) with a
preferential expression of Rae-1d. In the SVZ, mostly Rae-1d
transcripts were expressed (Fig. 2B). We then compared the
respective expression of RAE-1d and RAE-1e transcripts and
proteins in C57BL/6 cell lines and neurospheres obtained from
the SVZ (Fig. 2C). Preferential expression of Rae-1e transcripts
was observed in the C57sv cell line. The NOE olfactory epithelial
cell line only expressed RAE-1e and neurosphere cells preferen-
tially expressed RAE-1d as the SVZ. Using specific RAE-1e and
RAE-1d antibodies we observed that the pattern of protein
expression is similar to transcripts (Fig. 2D). Thus, transcriptional
regulation is probably the main process underlying the differential
expression of RAE-1d and RAE-1e.
We then compared by flow cytometry the binding of NKG2D/
Fc on HEK cells transfected with plasmids encoding RAE-1d,
RAE-1e or RAE-1c (Fig. 3). NKG2D bound to RAE-1e and RAE-
1c at low concentration (0.6 mg/ml) whereas binding to RAE-1d
was only detected at 2.5 mg/ml. At each concentration, NKG2D/
Fc binding to RAE-1e was stronger than to RAE-1c and
NKG2D/Fc binding to RAE-1c was stronger than to RAE-1d
(Fig. 3). RAE-1d is thus a poor NKG2D ligand.
In conclusion, we showed that RAE-1d and RAE-1e are two
different proteins and that their expression is differentially
regulated. We thus investigated the mechanisms controlling the
expression of each gene.
Rae-1d and Rae-1e transcription is under the control of
two distinct promoter regions
We first performed an in silico study of rae-1d and rae-1e
sequences to predict their promoters. We identified two promoter
regions for each gene, one localized upstream of exon 1 and a
second, upstream of exon 4 (Gene2promoter program, Genomatix
software).
We then analyzed all Rae-1 transcripts possibly generated by
these promoters in C57BL/6 cell lines and tissues using RT-PCR
and agarose gel analysis. The Ex5-Ex9 primer pair does not
discriminate the Rae-1d from the Rae-1e transcripts (data not
shown). Using these primers, we detected a single product. We
sequenced the liver PCR product obtained with those primers and
observed the superimposition of two sequences, one corresponding
to Rae-1d and the other one less represented corresponding to
Rae-1e (Figure S1). The figure 4 illustrates the results obtained
with Ex1-Ex6d and Ex1-Ex6e pairs that are gene-specific and may
reflect the activity of the putative promoter upstream of exon 1.
Using an exon 5 and exon 6d primer pair, Rae-1d transcripts were
detected in all tested conditions. However, we failed to detect Rae-
1d transcripts using the primer targeting exon 1 (Fig. 4, upper
Figure 1. Schematic representation of rae-1 genes. A, Exon/intron structure and localization of rae-1d and rae-1e genes on the 10 A3
chromosomal region. B, Representation of rae-1 genes. The most important differences between rae-1d and rae-1e are colored in grey.
doi:10.1371/journal.pone.0013466.g001
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the NOE cell line (referenced FJ594066 in GenBank) after
treatment with actinomycin D and cycloheximide which stabilize
RNA (data not shown). Finally, the primer pair targeting exon 1
and exon 6 of Rae-1e, allowed the detection of three main PCR
products, one full length and two alternative splicing products of
either exon 2 alone (402 bp) or exon 2 and exon 3 (336 bp) (Fig. 4,
middle panels) which were sequenced and referenced in GenBank,
FJ 594065, FJ594067 and FJ594068 respectively. These observa-
tions suggested that transcription of rae-1 genes is under the control
of two different promoter regions, one upstream of exon 1
controlling the expression of Rae-1e, and the second, upstream of
exon 5 mainly involved in the expression of Rae-1d.
To validate this hypothesis, we performed 59RACE experiments
starting from either exon 3 or exon 6d. The sequencing of the
product starting from exon 6d revealed a transcription start site 41
nucleotides upstream of exon 4 and the presence of an additional
exon that we named exon 3b (Fig. 5A), also found in the rae-1e
gene. Accordingly, former exon 3 was renamed exon 3a (Fig. 5A).
Sequencing of the products starting from exon 3a confirmed the
presence of a transcription start site 15 nucleotides upstream of
exon 1 of rae-1e gene (data not shown) as previously described for
rae-1a gene [9]. The exon 3b is absent from transcripts initiated at
the exon 1. This observation allowed us to test the expression of
Rae-1d or Rae-1e transcripts under the control of promoter 2
alone, which we called short transcripts. We performed PCR with
Figure 2. Expression of Rae-1 transcripts in C57BL/6 tissues and cell lines. A and B, Quantification of all Rae-1, Rae-1d and Rae-1e transcripts
in healthy tissues: 10-days-old embryo (E10), liver and different parts of the adult central nervous system: olfactory bulbs (OB), subventricular zone
(SVZ), spinal cord (SC), striatum (S), cerebellum (C) and hippocampus (H). Results were expressed as mean of 3 analyses +/2 SEM relatively to GAPDH
as endogenous control. C, Expression of RAE-1d and RAE-1e proteins analyzed on NOE and C57sv cell lines and neurosphere cells by flow cytometry
after staining with anti-RAE-1d or -RAE-1e antibodies and PE-labeled anti-rat immunoglobulins. D, Expression of Rae-1d and Rae-1e transcripts by NOE
and C57sv cell lines and neurosphere cells, quantified by qPCR.
doi:10.1371/journal.pone.0013466.g002
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short transcripts, and a reverse primer in exon 6, specific for either
Rae-1d or Rae-1e (Fig. 5B). We detected Rae-1d and Rae-1e short
transcripts in the liver. We did not detect any Rae-1e short
transcript in the NOE cell line suggesting that Rae-1e transcripts
are only long transcripts under the control of the promoter 1 in
this cell line (Fig. 5B).
We then compared the activity of each promoter regions to the
SV40 promoter (pGL3-C). For each gene, we cloned 1,600 bp
upstream of exon 1 and 5,646 bp upstream of exon 3b in the
pGL3-B vector. After transfection in NOE and C57sv Rae-1-
expressing cell lines, each promoter exhibited a high activity. The
activity of rae-1e promoter 1 was higher than the activity of rae-1d
promoter 1 (Fig. 5C).
In conclusion, we described two promoter regions responsible
for the production of several Rae-1d and Rae-1e transcripts. We
thus questioned the involvement of each promoter in cell lines and
tissues, including inflammatory pathological tissues, since Rae-1
expression is enhanced in these conditions [14]. Finally, since Rae-
1 expression is circadianly regulated in the liver of C57BL/6 mice,
we also addressed the role of each promoter region in this
circadian rhythm.
Quantification of Rae-1d and Rae-1e transcript levels
under the control of each promoter region in
physiological and pathological condition
The above precise description of rae-1d and rae-1e genes allowed
us to predict several transcripts possibly generated by each
promoter which are illustrated in the figure 6A. We designed
new sets of primers in order to quantify each Rae-1 predicted
transcript in cell lines and tissues. The PCR products obtained
with each primer pair are illustrated in figure 6A. Since we
detected the recruitment of NKG2D expressing cells in the spinal
cord during EAE and in the olfactory bulbs after axotomy (Figure
S2), we also investigated the expression of each transcript if these
inflammatory conditions.
As shown in figure 6B, the fibroblastic cell line C57sv expressed
significant levels of Rae-1d transcripts whereas the NOE cell line
was characterized by a very high expression level of only Rae-1e.
On the contrary, the levels of Rae-1d were higher than those of
Rae-1e in neurosphere cells, E10 embryonic tissue, liver and
pathological tissues. Analysis of the cell lines and tissues confirmed
that promoter 2 is mainly involved in the expression of Rae-1d and
that promoter 1 is involved in the expression of Rae-1e. Even
though they were detectable, only few Rae-1e transcripts included
exon 3b. The Ex5-Ex6e primer pair evaluated all Rae-1e
transcripts whereas the Ex1-Ex3a and Ex2-Ex3a primer pairs
indirectly revealed the levels of alternatively spliced products. No
clear difference of expression was detected either in vitro or in vivo
between these transcripts. Finally, in the liver and EAE spinal
cord, a discrepancy between the results obtained with Ex5-Ex6d
and Ex3b-Ex6d sets of primers was observed suggesting the
presence of at least another type of transcript not detected with
these sets of primers. Therefore, we performed additional PCR
with primers localized in exon 3a and in exon 6d. The sequencing
of the PCR product showed the absence of the exon3b. This result
suggested the presence in the rae-1d gene of another transcription
start site upstream of exon 3a.
Finally, we collected cDNA from C57BL/6 liver at different
time points and quantified the transcripts under the control of rae-
1e promoter 1, rae-1e promoter 2 and rae-1d promoter 2. We
confirmed that Rae-1 transcripts expression is circadianly
regulated in the C57BL/6 mice liver [10]. The study showed
diurnal rhythm with peak and trough at ZT (Zeitgeber Time) 4
and ZT 16 respectively, for all transcripts (Fig. 7). Because of the
differences between the promoters, we can postulate that another
transcriptional mechanism is involved in the circadian expression
of RAE-1.
Discussion
We described for the first time the high complexity of the
transcriptional expression of Rae-1d and Rae-1e in physiological
and pathological conditions. Each transcript variants of Rae-1d
and Rae-1e are differentially expressed according to tissues,
pathological conditions and cell lines. This differential expression
is mainly explained by the presence of two different promoter
regions. The first one, upstream of exon 1, is involved in the
expression of rae-1e. The second, mainly involved in the control
of rae-1d gene expression, is localized upstream of exon 4 and
induces transcripts using a start site upstream of exon 3b. We also
brought evidence of another potential start site upstream of exon
3a. The exon 3b is not retained in transcripts using this latter
start site.
In vivo, even though we could detect the expression of Rae-1e,
this expression was lower than that of Rae-1d. Conversely, in vitro,
except for neurosphere culture, cell lines mainly expressed RAE-
1e. Nausch et al. also observed that embryonic fibroblastic cell
lines established from C57BL/6 mice lacking JUNB, a subunit of
the AP-1 complex, express high levels of Rae-1e whereas the
expression of Rae-1d remained low [12]. rae-1e promoter regions
contain more AP-1 sites than those of rae-1d [12]. We hypothesize
that culture conditions of immortalized cell lines such as exposition
to fetal calf serum, plastic adhesion, high oxygen pressure or stress
induction could explain this preferential expression of RAE-1e
[15,16].
As most genes, rae-1 genes contain multiple exons/introns and
several non-coding exons. The process of pre-mRNA splicing is an
essential step in the expression of most genes [17,18]. For Rae-1e,
we characterized alternative splicing of non-coding exons 2 and 3a
but not of coding exons. This process thus did not contribute to the
diversification of the RAE-1 protein or the non-sense mediated
mRNA decay control mechanism. The biological significance of
this alternative splicing remains to be determined.
Figure 3. Comparison of NKG2D affinity for RAE-1 proteins. HEK
cell line was cotransfected with plasmids coding for EGFP as a
transfection efficiency control and either RAE-1d, RAE-1e or RAE-1c.
After 3 days of culture, cells were incubated with increasing
concentrations of NKG2D/Fc and PE-labeled anti-human IgG-Fc. Results
were expressed as: (PE MFI measured on EGFP positive cells) - (PE MFI
measured on EGFP negative cells).
doi:10.1371/journal.pone.0013466.g003
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characterized by a circadian rhythm. The circadian timing is
based on a complex network of feedback loops involving
transcriptional, post-transcriptional and post-translational events.
The main involved transcription factors are PER1, PER2, PER3,
CRY1, CRY2, CLOCK/BMAL1 heterodimers and STRA13, a
basic helix-loop-helix (bHLH) protein playing a role in the
mammalian circadian rhythm regulation by suppressing the
CLOCK/BMAL1 activation, but also via protein-protein inter-
actions with other transcription factors including BMAL1 [19].
STRA13 KO mice express lower levels of Rae-1 transcripts than
the control mice and their expression is not circadian [10]. Using
promoter inspector software, we failed detecting binding sites for
STRA13 or CLOCK/BMAL1 in the two rae-1 promoters.
Moreover, we showed that all Rae-1 transcripts, whatever the
used promoters, are circadianly expressed. We suggest that
regulation of RAE-1 circadian rhythm involves other mechanisms
under investigation such as mRNA stabilization or micro-RNAs
(miRNAs). Interestingly, the 39UTR regions of Rae-1d and Rae-
1e are almost identical and miRNAs have recently been studied in
the circadian rhythm of some genes [20]. In addition, it has
recently been shown that cellular miRNAs target the 39UTR of
the human NKG2D ligands, MICA and MICB [21,22].
The interest of our results is especially related to the observation
that RAE-1d is a weak NKG2D ligand compared to RAE-1e. In
vitro, neurosphere cells also preferentially express RAE-1d. This
may explain the resistance of neurosphere cells to NK cell
cytotoxicity [23] despite the absence of MHC-Ia expression. The
mouse cytomegalovirus (MCMV) developed different mechanisms
for preventing the anti-viral immune response. In particular, the
m152/gp40 glycoprotein of MCMV lowers the membrane
expression of RAE-1. Interestingly, the expression of RAE-1e (as
well as a, b and c) is affected but not the expression of RAE-1d
[24]. As RAE-1d is a poor NKG2D ligand, we can postulate a
more intensive viral effort to regulate RAE-1e than RAE-1d. The
down-regulation is due to a direct interaction between the m152
and RAE-1 proteins. The retention of RAE-1a, b and c depends
on the amino-acid sequence PLWY (position 19–22), deleted in
RAE-1d and substituted with LPWC in RAE-1e (Figure S3 A and
B) [25]. This sequence lies in an exposed loop connecting the b1
Figure 4. Characterization of Rae-1d and Rae-1e transcripts. A, RT-PCR analysis of Rae-1d transcripts using an exon 1-exon 6d primer pair or an
exon 5-exon 6d primer pair and of Rae-1e transcripts using an exon 1-exon 6e primer pair or an exon 5-exon 6e primer pair (see schematic in Fig. 6).
We compared the PCR products obtained from cell lines (C57sv, ES, NOE) and healthy tissues (10-days-old embryo (E10), liver, heart (He) and brain
(Br)); NTC, non template control.
doi:10.1371/journal.pone.0013466.g004
Rae1d and Rae1e Differences
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might also explain the low affinity of NKG2D/Fc for RAE-1d,
because the tryptophan at position 21 is involved in NKG2D
contact [26].
We postulate that immune function is mainly exerted by RAE-
1e and non-immune function by RAE-1d. RAE-1d, but not
NKG2D are detected in the SVZ. We demonstrated that RAE-1d
exerts a non-immune function on cell proliferation using the
neurosphere culture model and a loss of function approach [11].
The mechanism of action remains to be determined. We
hypothesize that, as other members of the MHC class-I family,
RAE-1 could be a partner for membrane receptors. For example,
HFE is a membrane partner of the transferrin receptor [27]. More
recently, Mill [28], the closest relative to NKG2D human ligand,
MICA, has been described to play roles in nutrient metabolism.
We observed that Rae-1d and Rae-1e transcript expression is
induced in the spinal cord of EAE mice and olfactory bulbs after
axotomy. We also described the recruitment of NK cells
expressing NKG2D which exert a neuroprotective role in EAE
[29,30]. It is thus necessary to identify which cells express RAE-1
in the pathological tissues. The first cells possibly expressing RAE-
1 are macrophages recruited in the spinal cord after inflammation
since LPS treated macrophages express RAE-1 [31]. Other
candidates would be neural stem cells since neurogenesis is
induced in the spinal cord after EAE [32] and in the olfactory
bulbs after axotomy [33].
In conclusion, several studies have improved the understanding
of NKG2D receptor-mediated activation, signaling and function
[34,35]. NKG2D recognizes a variety of inducible self-proteins
that belong to the non-classical MHC class I family. They include
H60 (a, b and c), RAE-1 (a-e) and MULT1 in mice. Organization
and sequence homology of NKG2D ligand family indicate that
they are generated by multiple rounds of gene duplication and
divergence from an ancestral prototypic gene [35]. These ligands
differ in their genomic organization, amino acid sequence, affinity
to NKG2D and more importantly in their expression patterns
Figure 5. Localization of the rae-1d transcriptional start site and activity of rae-1d and rae-1e promoters. The 59 RACE experiment was
performed on enriched polyA+ RNA isolated from liver. A, The 59 RACE product was sequenced and aligned with the rae-1d genomic sequence. B,
Detection in the liver and NOE cell line of Rae-1d and Rae-1e transcripts under the control of promoter 2 using a sense primer overlapping the exon
3b and the exon 4. C, NOE and C57sv cell lines were co-transfected with the luciferase reporter vector pGL3 Basic containing the different Rae-1
promoters or the pGL3-C vector containing the SV40 promoter and the pRL-null vector expressing renilla luciferase in order to assess the efficiency of
transfection and to normalize the activity of the firefly luciferase. Luciferase activity was measured on each triplicate wells 48 h after transfection. The
results are expressed as mean of 3 experiments in triplicate +/2 SEM of firefly/renilla luciferase activity ratio for each condition. The assays of
luciferase activity were analyzed with a MANOVA test (*: p,0.01 and **: p,0.001).
doi:10.1371/journal.pone.0013466.g005
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for a single activating receptor NKG2D is still lacking. It depends
on a detailed knowledge of their immunobiology and molecular
mechanisms regulating the expression of each ligand. We bring
herein new information for Rae-1d and Rae-1e, showing mainly
different functions and transcriptional regulation which may have
diverged together.
Materials and Methods
Mice
C57BL/6 mice were purchased from Janvier (France). All mice
were maintained under pathogen-free conditions in our animal
facility (Agreement number C13.055.8). All experiments were
performed according to the guidelines of the local ethical
committee on animal research.
Cell culture
Cell lines: We established the NOE cell line from the
olfactory epithelium of C57BL/6 mice [37]. The C57sv
fibroblast and the HEK 293 epithelial cell line were obtained
from the American Type Culture Collection (ATCC). The cell
lines were cultured in DMEM (Invitrogen) supplemented with
10% fetal calf serum, 100 U/ml penicillin-streptomycin and
2 mM L-glutamin (Invitrogen) and maintained at 37uCi n5 %
CO2.
Figure 6. Quantification of all Rae-1 transcripts in vivo and in vitro. A, Schematic representation of rae-1 genes with exons (boxes),
transcription start sites (bold arrows), intron splicing (bold doted lines) and alternative splicing (thin doted lines). Prediction of all Rae-1d and Rae-1e
transcripts under the control of either promoter 1 or promoter 2 and position of sets of primers allowing the detection and quantification of each
transcript. B, RT-qPCR of each transcript in 10-days-old embryo (E10), subventricular zone (SVZ), liver, olfactory bulbs (OB) from control or axotomized
mice, lumbar spinal cord (LSC) from mice suffering EAE and neurospheres (NS), C57sv and NOE cell lines. Results are expressed relatively to GAPDH as
endogenous control.
doi:10.1371/journal.pone.0013466.g006
Rae1d and Rae1e Differences
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were dissociated with trypsin-EDTA (Invitrogen) and cultured in a
proliferation medium containing 75% DMEM, 25% F12 Ham
(Invitrogen), ITS additive (insulin, transferrin, selenite; Invitrogen),
transferrin (100 mg/ml; Sigma), progesterone (20 nM; Sigma),
penicillin/streptomycin (100 U/ml; Invitrogen) supplemented
with bFGF (basic fibroblast growth factor, 10 ng/ml; Peprotech),
EGF (epidermal growth factor, 10 ng/ml; Peprotech) and B27
additive (1/50; Invitrogen) and maintained at 37uC in 5% CO2.
Flow Cytometry
3610
5 cells were stained for 15 min on ice with either anti-mouse
pan-RAE-1 (R&D systems, clone 186107), anti-mouse RAE-1e
(R&D systems; clone 205001), anti-mouse RAE-1d (R&D systems;
clone 199205),isotype controlsor themouse recombinant NKG2D/
Fc chimera (R&D systems) diluted in PBS 1% FCS, 0.02% sodium
azide and then incubated with PE labeled anti-rat antiserum
(Jackson ImmunoResearch Laboratories, Inc.) or with PE labeled
anti-human antiserum (Beckman Coulter). The cells were washed
and fixed with 2% paraformaldehyde (Sigma) in PBS EDTA 5 mM
and analyzed on FACSCanto (Becton Dickinson). The data were
analyzed with the CellQuest software (Becton Dickinson).
RNA extractions, RT-PCR and –qPCR
Tissues were dissected, weighted and placed in RNALater
solution (Qiagen, CA). Total RNA extraction of tissues and cell
lines were performed with the RNeasy Mini Kit (Qiagen). The
reverse transcription was performed with M-MLV reverse
transcriptase (Invitrogen). All primers are reported in Table S1.
PCR were performed on a T1 Thermocycler (Biometra) with the
Taq DNA Polymerase Recombinant (Invitrogen). The amplifica-
tion procedure was done as follows: 2 min. denaturation at 95uC,
40 cycles with 30 sec. at 95uC, 30 sec. of annealing at the
appropriate temperature and 30 sec. elongation at 72uC, and
finally 10 minutes elongation at 72uC. The PCR products were
loaded on 2% agarose gels containing SYBRSafe (Invitrogen).
Quantitative PCR was performed on Stratagene’s MX3000P
QPCR System with the Brilliant SYBR Green QPCR Master Mix
(Stratagene). The amplification procedure included a 10 minutes
step at 95uC followed by 40 cycles with 30 sec. at 95uC and 1 min
at 62uC and Melting Curve analysis. Results were expressed
relatively to GAPDH as endogenous control. For circadian rhythm
studies we used 36B4 as control [10].
Olfactory axotomy
Eight-week-old female mice were anesthetized with intraperito-
neal injections of Xylasin (10 mg/g body weight, Ronpum 2%,
Bayer) and Ketamin (0.1 mg/g body weight, Ke ´tamine 1000,
Virbac). An incision was made on the head along the midline of the
scalp.A craniotomy wasbilaterallyperformed over theanterior part
of the olfactory bulbs and the axons of the olfactory nerves were cut
with a needle. Sham-operated controls were subjected to the same
procedure but the axons were not sectioned. Then, the skin was
sutured and animals were sacrificed at Day 6 for analysis.
Experimental Autoimmune Encephalomyelitis
Eight-week-old female mice were immunized by injecting
subcutaneously 200 ml of an emulsion containing 200 mg of 35–
55 myelin oligodendrocyte glycoprotein (MOG) peptide (.95%
pure, Neosystem) in complete Freund adjuvant (CFA) (DIFCO)
supplemented with 400 mg of H37Ra Mycobacterium tuberculosis
(DIFCO). 50 ng of Bordetella pertussis toxin (Sigma) in 100 mlo f
PBS were injected intra-peritoneously at Day 0 and Day 1. The
animals were blindly monitored daily by weighing and clinical
scoring on a scale of 0 to 6 with the following criteria: 0: no deficit;
1: limp tail; 2: mild hind leg weakness; 3: half-paralysis of hind leg;
4: total hind leg paralysis; 5: fore leg and hind leg paralysis; 6:
moribund. Animals were sacrificed at Day 30, during the chronic
phase of the disease.
59RACE
Enrichment of polyA+ RNA from total RNA was performed
using the Qiagen oligotex mini kit according to the manufacturer’s
protocol. The 59 RACE was carried out with the 59-full RACE
Core Set kit (Takara) as follows: first, a reverse transcription using
the AMV reverse transcriptase XL was done with a 59
phosphorylated primer (Table S1), then 1 h RNaseH treatment
at 30uC was performed followed by a 12 h ligation with T4 DNA
ligase at 15uC. The unknown part of the sequence was amplified in
a first PCR with a primer couple S1A1 followed by a nested PCR
with primer couple S2A2 (Table S1). The final PCR products were
inserted into the pCRII-TOPO vector (Invitrogen) and sent for
sequencing (Genome Express).
Cloning methods and strategies
Promoter cloning. Genomic DNA was obtained from mouse
C57BL/6 liver with the Qiagen DNeasy blood and tissue kit.
Figure 7. All transcripts are characterized by a circadian rhythm. RT-qPCR were performed on C57BL/6 livers dissected at different Zeitgeber
time (ZT) with three sets of primers: exon 1-exon 3a primers which detected the Rae-1e transcripts under the control of the promoter 1, exon 3b with
either exon 6d or exon 6e primers allowing the quantification of transcripts under the control of the promoter 2. Results are expressed as mean of 3
livers +/2 SEM at each ZT relatively to GAPDH as endogenous control.
doi:10.1371/journal.pone.0013466.g007
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primers containing restriction sites for XhoI and HindIII (Table
S1) and the PrimeStar DNA polymerase (Lonza). Genomic DNA
upstream of exon 3b (5,651 bp for rae-1d and 5,474 bp for rae-1e)
was amplified with primers containing restriction sites for KpnI
and NheI and the PrimeStar DNA polymerase. The PCR
products were digested and joined in the pGL3 Basic Luciferase
reporter vector (Promega) with the T4 DNA ligase (Invitrogen).
We used as control the pGL3-C plasmid which contains the SV40
promoter.
Rae-1 cloning. The vector pEGFP-C1 (Clontech) was used to
express EGFP and to insert Rae-1 coding sequences after the
removal of the EGFP sequence between the NheI and BamHI
restriction sites. Rae-1d, Rae-1e and Rae-1c transcripts were
amplified from cDNA with primers containing NheI and BamHI
sites and the PrimeStar DNA polymerase (Lonza). The PCR
products were digested and joined in the vector with the T4 DNA
ligase. In all cases, the constructs were verified by sequencing
(Genome Express). For transfection, DNA was purified with the
Plasmid Purification kit for isolation of ultrapure, transfection
grade plasmid DNA (Qiagen).
Cell transfection and luciferase assay
Cells were transfected using JetPEI (Polyplus-transfection) with
the firefly luciferase reporter plasmids containing rae-1 promoters.
Transfection efficiency was assessed by the co-tranfection of pRL-
null plasmid (Promega) encoding Renilla luciferase. The luciferase
activity was measured with the Dual Luciferase Reporter assay
(Promega) on a Lumat LB 9507 (Berthold Technologies).
Supporting Information
Table S1 List of primers used for the different experiments of
PCR, quantitative PCR, 59 RACE and cloning strategies.
Found at: doi:10.1371/journal.pone.0013466.s001 (0.04 MB
XLS)
Figure S1 Sequence of PCR products from liver after amplifi-
cation with exon 5 and exon 9 primers. We observed the
superimposition of two sequences, one corresponding to Rae-1d
and the other, less represented, and corresponding to Rae-1e.
Found at: doi:10.1371/journal.pone.0013466.s002 (0.57 MB TIF)
Figure S2 NK cells are recruited in lumbar spinal cord after
EAE. A, Spinal cords were dissected 25 days after EAE induction
and NKp46 transcripts were quantified. Results were expressed as
mean of 3 analysis +/- SEM relatively to GAPDH as endogenous
control. Expression in healthy spinal cords (n=3) was compared
with expression in spinal cords from 3 mice suffering mild EAE
(clinical score 2) and 3 mice suffering severe EAE (clinical score 4).
B, Lymphocytes were isolated from spinal cord, 25 days after EAE
induction. The expression of NKG2D protein was analyzed by
flow cytometry in NK cells (blue population) and CD8
lymphocytes (green population) another cell population able to
express NKG2D.
Found at: doi:10.1371/journal.pone.0013466.s003 (0.65 MB TIF)
Figure S3 Comparison of RAE-1 sequences and illustration of
the exposed loop of RAE-1c,d and e. A, Amino acid sequences of
RAE-1ad, b, c, d and e were aligned using ClustalW. Secondary
structure elements are identified (black arrows for b-sheets, and
white cylinders for a-helix) based on RAE-1b three-dimensional
structure (PDB entry 1JFM. The PLWY motif (localized between
sheets b-1 and b-2) was highlighted in red for all five sequences. B,
Ribbon diagrams of RAE-1c, d and e were obtained by replacing
amino acids from the crystal structure of RAE-1b (PDB entry
1JFM) and using the SWISS-MODEL server to generate the
calculated structure of each isoform. On the left panel the
‘KDPTPADPLWY’ loop (between sheets b-1 and b-2) was
highlighted in purple, Trp51 previously involved in ‘RAE-1-
NKG2D’ recognition is shown in yellow, and Tyr52 in orange. In
the central panel, RAE-1d exhibits a shorter loop due to the
‘PLWY’ deletion. In RAE-1e, right panel, mutations (i.e. ‘LPWC’)
do not alter the structure of this loop. Trp51 (yellow) and Cys52
(red) are shown as stick representations superposed on the ribbons.
The structures are visualized using Pymol software (The PyMOL
Molecular Graphics System, Version 1.2r3pre, Schro ¨dinger, LLC,
http://www.pymol.org/).
Found at: doi:10.1371/journal.pone.0013466.s004 (1.71 MB TIF)
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